JP2002542293A5 - - Google Patents

Download PDF

Info

Publication number
JP2002542293A5
JP2002542293A5 JP2000613441A JP2000613441A JP2002542293A5 JP 2002542293 A5 JP2002542293 A5 JP 2002542293A5 JP 2000613441 A JP2000613441 A JP 2000613441A JP 2000613441 A JP2000613441 A JP 2000613441A JP 2002542293 A5 JP2002542293 A5 JP 2002542293A5
Authority
JP
Japan
Prior art keywords
secopregna
triene
dihydroxy
hydroxy
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000613441A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002542293A (ja
JP4426729B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2000/000033 external-priority patent/WO2000064450A1/en
Publication of JP2002542293A publication Critical patent/JP2002542293A/ja
Publication of JP2002542293A5 publication Critical patent/JP2002542293A5/ja
Application granted granted Critical
Publication of JP4426729B2 publication Critical patent/JP4426729B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000613441A 1999-04-23 2000-01-27 医薬組成物 Expired - Lifetime JP4426729B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK199900561 1999-04-23
DKPA199900561 1999-04-23
PCT/DK2000/000033 WO2000064450A1 (en) 1999-04-23 2000-01-27 Pharmaceutical composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008191182A Division JP5721926B2 (ja) 1999-04-23 2008-07-24 医薬組成物

Publications (3)

Publication Number Publication Date
JP2002542293A JP2002542293A (ja) 2002-12-10
JP2002542293A5 true JP2002542293A5 (cg-RX-API-DMAC7.html) 2008-05-22
JP4426729B2 JP4426729B2 (ja) 2010-03-03

Family

ID=8094933

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2000613441A Expired - Lifetime JP4426729B2 (ja) 1999-04-23 2000-01-27 医薬組成物
JP2008191182A Expired - Lifetime JP5721926B2 (ja) 1999-04-23 2008-07-24 医薬組成物
JP2013014098A Pending JP2013075923A (ja) 1999-04-23 2013-01-29 医薬組成物
JP2015090105A Expired - Lifetime JP5886999B2 (ja) 1999-04-23 2015-04-27 医薬組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2008191182A Expired - Lifetime JP5721926B2 (ja) 1999-04-23 2008-07-24 医薬組成物
JP2013014098A Pending JP2013075923A (ja) 1999-04-23 2013-01-29 医薬組成物
JP2015090105A Expired - Lifetime JP5886999B2 (ja) 1999-04-23 2015-04-27 医薬組成物

Country Status (30)

Country Link
US (1) US6753013B1 (cg-RX-API-DMAC7.html)
EP (5) EP2915534B1 (cg-RX-API-DMAC7.html)
JP (4) JP4426729B2 (cg-RX-API-DMAC7.html)
KR (1) KR100694526B1 (cg-RX-API-DMAC7.html)
CN (1) CN1173703C (cg-RX-API-DMAC7.html)
AU (1) AU774600B2 (cg-RX-API-DMAC7.html)
BG (1) BG65115B1 (cg-RX-API-DMAC7.html)
BR (3) BRPI0009956B8 (cg-RX-API-DMAC7.html)
CA (1) CA2370565C (cg-RX-API-DMAC7.html)
CY (5) CY1113967T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ303142B6 (cg-RX-API-DMAC7.html)
DK (5) DK3146969T3 (cg-RX-API-DMAC7.html)
ES (5) ES2432691T3 (cg-RX-API-DMAC7.html)
HK (1) HK1045650B (cg-RX-API-DMAC7.html)
HR (1) HRP20010779B1 (cg-RX-API-DMAC7.html)
HU (1) HU230045B1 (cg-RX-API-DMAC7.html)
IL (2) IL145983A0 (cg-RX-API-DMAC7.html)
IS (1) IS6120A (cg-RX-API-DMAC7.html)
LT (2) LT3146969T (cg-RX-API-DMAC7.html)
ME (1) ME00298B (cg-RX-API-DMAC7.html)
MX (1) MXPA01010676A (cg-RX-API-DMAC7.html)
NO (1) NO329486B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ515142A (cg-RX-API-DMAC7.html)
PL (1) PL199123B1 (cg-RX-API-DMAC7.html)
PT (5) PT3146969T (cg-RX-API-DMAC7.html)
RS (1) RS52182B (cg-RX-API-DMAC7.html)
RU (1) RU2238734C2 (cg-RX-API-DMAC7.html)
SI (3) SI1178808T1 (cg-RX-API-DMAC7.html)
SK (1) SK287653B6 (cg-RX-API-DMAC7.html)
WO (1) WO2000064450A1 (cg-RX-API-DMAC7.html)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
CN1173703C (zh) 1999-04-23 2004-11-03 里奥药物制品有限公司 药物组合物
WO2006120681A2 (en) * 2005-05-10 2006-11-16 Dermipsor Ltd. Compositions and methods for skin care
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
DK1330468T3 (da) * 2000-09-18 2007-11-05 Serono Lab Svovlanaloger af 21 hydroxy-6,19-oxido-progesteron (21OH 6OP) til behandling af overskud af glucocorticoider
WO2002034235A1 (en) * 2000-10-27 2002-05-02 Leo Pharma A/S Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20050101576A1 (en) * 2003-11-06 2005-05-12 Novacea, Inc. Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
US7351869B2 (en) * 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
EP1854466A1 (en) * 2002-12-17 2007-11-14 Galderma Research & Development, S.N.C. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
PL374777A1 (en) * 2002-12-17 2005-10-31 Galderma Sa Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
JP2004359585A (ja) * 2003-06-03 2004-12-24 Medorekkusu:Kk 被膜形成型の副腎皮質ステロイド薬含有外用製剤
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
PE20050359A1 (es) * 2003-08-12 2005-06-27 Novartis Consumer Health Sa Composiciones topicas que comprenden terbinafina e hidrocortisona
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20070299041A1 (en) * 2004-05-26 2007-12-27 Cedars-Sinai Medical Center Induction of innate immunity by vitamin d3 and its analogs
JP2008502647A (ja) * 2004-06-17 2008-01-31 ガルデルマ・ソシエテ・アノニム シリコーン剤、コルチコステロイドおよびビタミンdまたはその誘導体を含む乾癬治療用組成物
MXPA06014397A (es) * 2004-06-17 2007-02-15 Galderma Sa Composicion en forma de aerosol que comprende una combinacion de un corticoide y un derivado de la vitamina d en una fase aceitosa.
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
CA2567684A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
FR2871695B1 (fr) 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
JP2006131544A (ja) * 2004-11-05 2006-05-25 Medorekkusu:Kk 皮膚疾患治療用外用剤
US7244719B2 (en) * 2004-11-22 2007-07-17 Wisconsin Alumni Research Foundation 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
JP2008540514A (ja) * 2005-05-10 2008-11-20 ダーミプソル リミテッド 過剰増殖表皮疾患の治療用組成物及び方法
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
RU2412165C2 (ru) 2006-03-17 2011-02-20 Лео Фарма А/С Изомеризация фармацевтических интермедиатов
ES2334381T3 (es) * 2006-08-17 2010-03-09 Klever Mode, S.L. Formulacion farmaceutica para el tratamiento de afecciones en la piel.
BRPI0715636A2 (pt) * 2006-08-29 2013-07-02 Teva Pharma composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo
CA2662864A1 (en) * 2006-09-28 2008-04-03 Wisconsin Alumni Research Foundation 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
EP2069297A1 (en) * 2006-09-28 2009-06-17 Wisconsin Alumni Research Foundation 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) * 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
CA2739376A1 (en) 2008-10-03 2010-04-08 Nexmed Holdings, Inc. Stabilized composition for treating psoriasis
RU2396081C1 (ru) * 2008-12-29 2010-08-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения дерматозов, поддающихся глюкокортикостероидной терапии, и способ ее получения
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2761039A1 (en) * 2009-05-07 2010-11-11 Tolmar, Inc. Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US20110053898A1 (en) * 2009-08-26 2011-03-03 Glenmark Generics Ltd Topical composition comprising vitamin d analogue and corticosteroids
KR20150043548A (ko) 2009-10-01 2015-04-22 앱탈리스 파마테크, 인코포레이티드 경구 투여용 코르티코스테로이드 조성물
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
MX2012007225A (es) * 2009-12-22 2012-07-30 Leo Pharma As Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
EP2579852B1 (en) 2010-06-11 2014-12-31 Leo Pharma A/S A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US9610245B2 (en) 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN103110648A (zh) * 2013-01-25 2013-05-22 江苏圣宝罗药业有限公司 钙泊三醇倍他米松软膏及其制备方法
US20150376161A1 (en) 2013-01-29 2015-12-31 Avexxin As Antiiflammatory and antitumor 2-oxothiazoles abd 2-oxothiophenes compounds
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104666312B (zh) * 2015-02-12 2017-11-07 重庆华邦制药有限公司 含有卡泊三醇和二丙酸倍他米松的制剂
MA41818A (fr) * 2015-03-27 2018-01-30 Leo Pharma As Timbre à micro-aiguilles pour administration d'un principe actif à la peau
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
KR101641372B1 (ko) * 2015-05-08 2016-07-20 (주)동구바이오제약 안정성과 피부투과율이 향상된 약학 조성물
CN107157917B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种用于治疗银屑病的软膏的制备方法
CN107157919B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种用于治疗银屑病的半固体制剂的制备方法
CN107157918B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种用于银屑病治疗的半固体制剂的制备方法
CN107157920B (zh) * 2016-03-08 2019-12-27 上海通用药业股份有限公司 一种包含维生素d或其衍生物的半固体制剂的制备方法
GB201604318D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
WO2019072353A1 (en) * 2017-10-11 2019-04-18 Elmasry Mohamed Zakria Ahmed Ali TOPICAL PHARMACEUTICAL PREPARATION OF BETAMETHASONE, CALCIPOTRIOL AND ROSE OIL FOR THE TREATMENT OF PSORIASIS
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
WO2020010108A1 (en) 2018-07-05 2020-01-09 The General Hospital Corporation Compositions and methods for local delivery of pharmaceutical agents to treat cancer
FR3083701B1 (fr) 2018-07-13 2020-08-14 Gifrer Barbezat Liniment oleo-alcalin
US12691128B2 (en) 2019-10-01 2026-07-28 Ellodi Pharmaceuticals, L.P. Methods of treating eosinophilic esophagitis and reducing candidiasis
WO2021187593A1 (ja) * 2020-03-19 2021-09-23 シオノギヘルスケア株式会社 ベタメタゾン吉草酸エステル含有組成物
PT4255442T (pt) * 2020-12-04 2025-05-19 Incyte Corp Inibidor de jak com um análogo da vitamina d para o tratamento de doenças da pele
US12642802B2 (en) 2021-12-03 2026-06-02 Incyte Corporation Topical formulations of ruxolitinib with an organic amine pH adjusting agent for treatment of skin diseases
CN115177586A (zh) * 2022-08-31 2022-10-14 江苏知原药业股份有限公司 一种卡泊三醇组合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB892127A (en) 1958-03-03 1962-03-21 Merck & Co Inc Therapeutic preparations comprising steroids and vitamin d
DK116528A (cg-RX-API-DMAC7.html) * 1966-09-30
US4083974A (en) † 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JP2522962B2 (ja) * 1986-09-19 1996-08-07 中外製薬株式会社 乾癬治療剤
US4847071A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
GB8821129D0 (en) * 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition
GB8904154D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
US5087620A (en) 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
IL99368A (en) 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
JPH07173053A (ja) * 1993-12-20 1995-07-11 Otsuka Pharmaceut Co Ltd 抗微生物剤
JP3506474B2 (ja) 1994-01-07 2004-03-15 帝人株式会社 安定性の向上した乾癬治療剤
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US5840925A (en) * 1995-06-29 1998-11-24 Hauser, Inc. Trioxane dimer compounds having antiproliferative and antitumor activities
WO1997013518A1 (en) * 1995-10-10 1997-04-17 Marilyn Strube Treatment of pruritus with vitamin d and analogs thereof
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
JPH1067757A (ja) * 1996-06-21 1998-03-10 Ss Pharmaceut Co Ltd トリアゾール誘導体またはその塩
JPH10139669A (ja) * 1996-11-05 1998-05-26 Teijin Ltd 脂漏性角化症治療剤
US6017908A (en) * 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
DE69832699T2 (de) * 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
KR20010032892A (ko) * 1997-12-09 2001-04-25 나가야마 오사무 비타민 d3유도체를 함유하는 크림제
JP4387465B2 (ja) * 1997-12-09 2009-12-16 中外製薬株式会社 ビタミンd3誘導体を含有するローション剤
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
JPH11246329A (ja) * 1998-02-27 1999-09-14 Shiseido Co Ltd 皮膚外用剤
PL192825B1 (pl) * 1998-03-04 2006-12-29 Teijin Ltd Płyn w postaci emulsji z aktywną witaminą D3
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US5886038A (en) 1998-03-24 1999-03-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
CN1173703C (zh) * 1999-04-23 2004-11-03 里奥药物制品有限公司 药物组合物

Similar Documents

Publication Publication Date Title
CN1102410C (zh) 莫匹罗星钙盐的乳膏组合物
JP2677554B2 (ja) 乾燥した微粒子のさらさらした安定なトコフエロール
BR0314028A (pt) Sistema estruturante, processo para sua preparação, composição lìquida para tratamento de tecidos e método para controle do tamanho de partìcula
JP2002536315A5 (cg-RX-API-DMAC7.html)
WO2003045411A3 (de) Ingwer-extraktzubereitung
SI3146969T1 (en) Ointment for topical treatment of psoriasis
IE57732B1 (en) Pharmaceutical composition
IL272954B1 (en) Methods to reduce the generation of particles and preparations created by them
SUGDEN et al. Rat pineal α 1-adrenoceptors: identification and characterization using [125I] iodo-2-[β-(4-hydroxyphenyl)-ethylaminomethyl] tetralone
BR9810729B1 (pt) composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante.
EP1813274A4 (en) MEDICAL COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR STABILIZING A DIHYDROPYRIDINE COMPOUND IN A MEDICAL COMPOSITION
BR0013385A (pt) Composições farmacêuticas para administração oral e tópica
EP4635577A3 (en) Water-resistant and/or photoprotective compositions comprising non-solubilized micronized waxes
IL162496A0 (en) Pharmaceutical compositions containing cyclosporin
JPH0640928A (ja) アントシアノシド類を含有する経口医薬組成物
CN1201786A (zh) 苯磺酰胺化合物
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
ES2040503T3 (es) Oxido de magnesio en forma de polvo fino y su aplicacion.
OA12008A (en) Bioavailable dosage form of isotretinoin.
BR0318242A (pt) derivados de azabiciclo hexano substituìdo como antagonistas de receptores muscarìnicos e processo para sua preparação
DE59913493D1 (de) Zweiphasige Zusammensetzung mit Tramadol
CN1943339A (zh) 一种农药水乳剂及其制备方法
IE43270B1 (en) Steroid compositions
TW200724603A (en) Polyalkoxylate-comprising solid formulations, processes for their preparation and their use
KR101755407B1 (ko) 건선의 예방 또는 치료용 약제학적 조성물